Glycosaminoglycans in thyroid eye disease

Area of Science:

• Biochemistry
• Ophthalmology
• Endocrinology

Background:

• Thyroid eye disease (TED) is characterized by orbital tissue expansion and exophthalmos.
• This expansion is linked to the accumulation of hydrophilic glycosaminoglycans (GAGs) in the retrobulbar space.
• The precise role of GAG distribution and composition in TED pathogenesis requires further elucidation.

Purpose of the Study:

• To investigate the role of altered glycosaminoglycan (GAG) distribution and biochemical composition in thyroid eye disease (TED).
• To develop and validate a high-pressure liquid chromatography (HPLC) method for quantifying specific GAGs.
• To assess GAGs as potential biomarkers for TED activity and treatment response.

Main Methods:

• Development of a highly specific high-pressure liquid chromatography (HPLC) method.
• Quantification of total GAG, chondroitin sulfate A (CA), dermatan sulfate (DS), and hyaluronic acid (HA) in patient and control samples.
• Analysis of GAG distribution in orbital tissue extracellular matrix.

Main Results:

• Significant differences in urinary concentrations of total GAG and hyaluronic acid (HA) were observed between TED patients and controls.
• Elevated urinary chondroitin sulfate A (CA) levels were found in TED patients.
• Orbital tissue analysis revealed increased CA and HA fractions in TED patients compared to controls.
• The developed HPLC method demonstrated high sensitivity (0.86-0.87) for active/untreated disease and high specificity (1.0) for inactive disease.
• Patients with elevated GAG concentrations showed positive responses to steroids and/or orbital irradiation.

Conclusions:

• Glycosaminoglycans (GAGs) play a significant role in the pathogenesis of thyroid eye disease (TED).
• Specific GAGs, including chondroitin sulfate A (CA) and hyaluronic acid (HA), are altered in TED patients.
• The measurement of GAGs can serve as a valuable activity marker for thyroid eye disease (TED).